Outcome of Board Meeting
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 13.6 pts more than Nifty Microcap 250 and 14.1 pts more than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Jaysynth Orgochem Limited's Board approved the audited standalone and consolidated financial results for Q4 and FY ended 31st March 2026. The Board appointed M/s. Mehta Tanna & Associates as Internal Auditor for FY 2026-27. A new Wholly Owned Subsidiary will be incorporated in Hong Kong to support trading activities, procurement functions, and export opportunities. The Board recommended a 2% dividend on Preference Shares and a 5% dividend (Rs 0.05 per share) on Equity Shares for FY 2025-26, both subject to shareholder approval at the AGM.
The company declared dividends on both preference and equity shares, indicating profitability. The Hong Kong WOS expansion signals international business growth plans. However, no specific financial numbers were disclosed in this filing, so investors should await the detailed financial results for revenue and profit assessment.